Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone

References

• Wood SH, Mortola JF, Chan YF, et al. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol 1992; 80: 339–44
   PubMed Web of Science ®Google Scholar
• Sundström I, Bäckström T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuro-endocrinology 1998; 23: 73–88
   PubMed Web of Science ®Google Scholar
• Bancroft J, Bäckström T. Premenstrual syndrome. Clin Endocrinol 1985; 22: 313–36
   PubMed Web of Science ®Google Scholar
• Halbreich U, Endicott J, Lesser J. The clinical diagnosis and classification of premenstrual changes. Can J Psychiatry 1985; 30: 489–97
   PubMed Web of Science ®Google Scholar
• Korzekwa MI, Steiner M. Premenstrual syndromes. Clin Obstet Gynecol 1997; 40: 564–76
   PubMed Web of Science ®Google Scholar
• Janowsky DS, Berens DC, Davis JM. Correlations between mood, weight and electrolytes during the menstrual cycle: a renin–angiotensin–aldosterone hypothesis of premenstrual tension. Psychosom Med 1973; 35: 143–54
   PubMed Web of Science ®Google Scholar
• Munday M, Brush MG, Taylor RW. Correlations between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome. Clin Endocrinol 1981; 14: 1–9
   PubMed Web of Science ®Google Scholar
• Andersch B, Hahn L, Andersson M, et al. Body water and weight in patients with premenstrual tension. Br J Obstet Gynaecol 1978; 85: 546–50
   PubMedGoogle Scholar
• Davidson BJ, Rea CD, Valenzuela GJ. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Fertil Steril 1988; 50: 743–6
   PubMed Web of Science ®Google Scholar
• Cerin Å, Collins A, Landgren B-M, et al. Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. Acta Obstet Gynecol Scand 1993; 72: 337–43
   PubMed Web of Science ®Google Scholar
• Burton G, Galigniana M, De Lavallaz S, et al. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids. Mol Pharmacol 1995; 47: 535–43
   PubMedGoogle Scholar
• Parker CR, Winkel CA, Rush AJ, et al. Plasma concentrations of 11-desoxycorticosterone in women during the menstrual cycle. Obstet Gynecol 1981; 58: 26–30
   PubMed Web of Science ®Google Scholar
• Antonipillai I, Moghissi E, Hawks D, et al. The origin of plasma desoxycorticosterone in men and in women during the menstrual cycle. J Clin Endocrinol Metab 1983; 56: 93–8
   PubMedGoogle Scholar
• Winkel CA, Parker CR, Simpson ER, et al. Production rate of desoxycorticosterone in women during the follicular and luteal phases of the ovarian cycle: the role of extraadrenal 21-hydroxylation of circulating progesterone in desoxycorticosterone production. J Clin Endocrinol Metab 1980; 51: 1354–8
   PubMed Web of Science ®Google Scholar
• Kraulis I, Foldes G, Traikov H, et al. Distribution, metabolism and biological activity of deoxycorticosterone in the central nervous system. Brain Res 1975; 88: 1–14
   PubMedGoogle Scholar
• Teschemacher A, Zeise ML, Holsboer F, et al. The neuroactive steroid 5 alpha-tetrahydro-deoxycorticosterone increases GABAergic postsynaptic inhibition in rat neocortical neurons in vitro. J Neuroendocrinal 1995; 7: 233–40
   PubMedGoogle Scholar
• Wieland S, Lan NC, Mirasedeghi S, et al. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Brain Res 1991; 565: 263–8
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Johnson NJ. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav 1998; 59: 221–32
   PubMed Web of Science ®Google Scholar
• Wang M, Seippel L, Purdy RH, et al. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 1996; 81: 1076–82
   PubMed Web of Science ®Google Scholar
• Sundström I, Andersson A, Nyberg S, et al. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998; 67: 126–38
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Premenstrual dysphoric disorder. Diagnostic and Statistical Manual of Mental Disorders 4th edn. American Psychiatric Association, Washington, DC 1994; 714–18
   Google Scholar
• Hammarbäck S, Bäckström T, MacGibbon-Taylor B. Diagnosis of premenstrual syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Gynaecol 1989; 10: 25–42
   Web of Science ®Google Scholar
• Bäckström T, Carlström K, von Schoultz B, et al. Effect of progesterone, administered via intra-vaginal rings, on serum concentrations of oestradiol, FSH, LH and prolactin in women. J Reprod Fertil 1982; 64: 53–8
   PubMedGoogle Scholar
• Manlimos FS, Maroulis GB, Abraham GE. Radioimmunoassay of plasma 11-desoxy-corticosterone. Anal Lett 1975; 8: 931–8
   Web of Science ®Google Scholar
• Brenner PF, Guerrero R, Cekan Z, et al. Radioimmunoassay method for six steroids in human plasma. Steroids 1973; 22: 775–94
   PubMed Web of Science ®Google Scholar
• Aitken RCB. Measurements of feelings using visual scale. Proc R Soc Med 1969; 62: 989–93
   PubMedGoogle Scholar
• Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psychophysiological classroom experiment. Br J Clin Pharmacol 1978; 6: 15–21
   PubMed Web of Science ®Google Scholar
• Callahan LF, Pinctus T. A clue from self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. The P-VAS: D-ADL ratio. Arthritis Rheum 1990; 33: 1317–22
   PubMedGoogle Scholar
• Jorgensen J, Rossignol AM, Bonnlander H. Evidence against multiple premenstrual syndromes: results of a multivariate profile analysis of premenstrual symptomatology. J Psychosom Res 1993; 37: 257–63
   PubMed Web of Science ®Google Scholar
• Hammarbäck S, Bäckström T, Hoist J, et al. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985; 64: 393–7
   PubMed Web of Science ®Google Scholar
• Wang M, Hammarbäck S, Lindhe BA, et al. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet Gynecol Scand 1995; 74: 803–8
   PubMed Web of Science ®Google Scholar
• Ekholm UB, Hammarbäck S, Bäckström T. Premenstrual syndrome: changes in symptom pattern between two menstrual cycles. J Psychosom Obstet Gynecol 1992; 13: 107–19
   Web of Science ®Google Scholar
• MacGregor EA, Chia H, Vohrah RC, Wilkinson M. Migraine and menstruation: a pilot study. Cephalalgia 1990; 10: 305–10
   PubMed Web of Science ®Google Scholar
• Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976; 54: 321–47
   PubMed Web of Science ®Google Scholar
• Ottoson U-B, Carlström K, Damber J-E, et al. Serum levels of progesterone and some of its metabolites including desoxycorticosterone after oral and parenteral administration. Br J Obstet Gynaecol 1984; 91: 1111–19
   PubMedGoogle Scholar